470 related articles for article (PubMed ID: 29399439)
1. Plant flavone apigenin: An emerging anticancer agent.
Shankar E; Goel A; Gupta K; Gupta S
Curr Pharmacol Rep; 2017 Dec; 3(6):423-446. PubMed ID: 29399439
[TBL] [Abstract][Full Text] [Related]
2. Apigenin: a promising molecule for cancer prevention.
Shukla S; Gupta S
Pharm Res; 2010 Jun; 27(6):962-78. PubMed ID: 20306120
[TBL] [Abstract][Full Text] [Related]
3. Apigenin's Therapeutic Potential Against Viral Infection.
Lee IG; Lee J; Hong SH; Seo YJ
Front Biosci (Landmark Ed); 2023 Oct; 28(10):237. PubMed ID: 37919082
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone.
Tang D; Chen K; Huang L; Li J
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):323-330. PubMed ID: 27766890
[TBL] [Abstract][Full Text] [Related]
5. Apigenin and cancer chemoprevention: progress, potential and promise (review).
Patel D; Shukla S; Gupta S
Int J Oncol; 2007 Jan; 30(1):233-45. PubMed ID: 17143534
[TBL] [Abstract][Full Text] [Related]
6. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives.
Salmani JMM; Zhang XP; Jacob JA; Chen BA
Chin J Nat Med; 2017 May; 15(5):321-329. PubMed ID: 28558867
[TBL] [Abstract][Full Text] [Related]
7. Dietary flavonoids: bioavailability, metabolic effects, and safety.
Ross JA; Kasum CM
Annu Rev Nutr; 2002; 22():19-34. PubMed ID: 12055336
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties.
Cai H; Boocock DJ; Steward WP; Gescher AJ
Cancer Chemother Pharmacol; 2007 Jul; 60(2):257-66. PubMed ID: 17089164
[TBL] [Abstract][Full Text] [Related]
9. Apigenin and Breast Cancers: From Chemistry to Medicine.
Nabavi SM; Habtemariam S; Daglia M; Nabavi SF
Anticancer Agents Med Chem; 2015; 15(6):728-35. PubMed ID: 25738871
[TBL] [Abstract][Full Text] [Related]
10. Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress.
Singh D; Khan MA; Akhtar K; Arjmand F; Siddique HR
Toxicol Appl Pharmacol; 2022 Jul; 447():116072. PubMed ID: 35613639
[TBL] [Abstract][Full Text] [Related]
11. Flavones and flavonols may have clinical potential as CK2 inhibitors in cancer therapy.
McCarty MF; Assanga SI; Lujan LL
Med Hypotheses; 2020 Aug; 141():109723. PubMed ID: 32305811
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications.
Charrière K; Schneider V; Perrignon-Sommet M; Lizard G; Benani A; Jacquin-Piques A; Vejux A
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732259
[TBL] [Abstract][Full Text] [Related]
13. Apigenin: A dietary flavonoid with diverse anticancer properties.
Madunić J; Madunić IV; Gajski G; Popić J; Garaj-Vrhovac V
Cancer Lett; 2018 Jan; 413():11-22. PubMed ID: 29097249
[TBL] [Abstract][Full Text] [Related]
14. Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma.
Singh D; Khan MA; Mishra D; Goel A; Ansari MA; Akhtar K; Siddique HR
Transl Oncol; 2024 May; 43():101920. PubMed ID: 38394865
[TBL] [Abstract][Full Text] [Related]
15. Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds.
Chagas MDSS; Behrens MD; Moragas-Tellis CJ; Penedo GXM; Silva AR; Gonçalves-de-Albuquerque CF
Oxid Med Cell Longev; 2022; 2022():9966750. PubMed ID: 36111166
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones.
Grigalius I; Petrikaite V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215574
[TBL] [Abstract][Full Text] [Related]
17. Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment.
Allemailem KS; Almatroudi A; Alharbi HOA; AlSuhaymi N; Alsugoor MH; Aldakheel FM; Khan AA; Rahmani AH
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927560
[TBL] [Abstract][Full Text] [Related]
18. Flavones as colorectal cancer chemopreventive agents--phenol-o-methylation enhances efficacy.
Cai H; Sale S; Schmid R; Britton RG; Brown K; Steward WP; Gescher AJ
Cancer Prev Res (Phila); 2009 Aug; 2(8):743-50. PubMed ID: 19638489
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.
Tong X; Pelling JC
Anticancer Agents Med Chem; 2013 Sep; 13(7):971-8. PubMed ID: 23272913
[TBL] [Abstract][Full Text] [Related]
20. Insights into novel anticancer applications for apigenin.
Kowalczyk A; Bodalska A; Miranowicz M; Karłowicz-Bodalska K
Adv Clin Exp Med; 2017 Oct; 26(7):1143-1146. PubMed ID: 29211364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
